OBJECTIVE: The aim was to examine the psychometric properties of the Questionnaire on Stress in Cancer Patients (QSC-R10), a 10-item screening instrument for self-assessment of psychosocial distress in cancer patients. METHODS: A total of 1850 cancer patients were assessed with the QSC-R10. Patients were recruited from different inpatient and outpatient settings in Germany between 2007 and 2009. RESULTS: Mean age of the sample was 62.9 (SD=12.4) with breast cancer as the most frequent diagnosis (35.2%). The analysis indicated high reliability (Cronbach's α=0.85) and test-retest reliability (ICC=0.89). Validation scales included the Hospital Anxiety and Depression Scale (HADS), Distress-Thermometer (DT), European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) and Karnofsky Performance Status (KPS). Convergent validity was highest for the HADS total score (r=0.74) and the lowest correlation for KPS (r=-0.36). The QSC-R10 significantly distinguished subgroups by their clinical characteristics (metastases, illness duration, previous psychiatric treatment and psycho-oncological support; p<0.001). A cutoff score of >14 demonstrated good sensitivity (81.0%) and specificity (73.2%) and is suitable to determine the need for psychosocial support. CONCLUSION: The QSC-R10 is a valid and reliable questionnaire to detect distress in cancer patients with high acceptance among professionals and patients.
OBJECTIVE: The aim was to examine the psychometric properties of the Questionnaire on Stress in CancerPatients (QSC-R10), a 10-item screening instrument for self-assessment of psychosocial distress in cancerpatients. METHODS: A total of 1850 cancerpatients were assessed with the QSC-R10. Patients were recruited from different inpatient and outpatient settings in Germany between 2007 and 2009. RESULTS: Mean age of the sample was 62.9 (SD=12.4) with breast cancer as the most frequent diagnosis (35.2%). The analysis indicated high reliability (Cronbach's α=0.85) and test-retest reliability (ICC=0.89). Validation scales included the Hospital Anxiety and Depression Scale (HADS), Distress-Thermometer (DT), European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) and Karnofsky Performance Status (KPS). Convergent validity was highest for the HADS total score (r=0.74) and the lowest correlation for KPS (r=-0.36). The QSC-R10 significantly distinguished subgroups by their clinical characteristics (metastases, illness duration, previous psychiatric treatment and psycho-oncological support; p<0.001). A cutoff score of >14 demonstrated good sensitivity (81.0%) and specificity (73.2%) and is suitable to determine the need for psychosocial support. CONCLUSION: The QSC-R10 is a valid and reliable questionnaire to detect distress in cancer patients with high acceptance among professionals and patients.
Authors: Andreas Dinkel; Marielouise Kornmayer; Jürgen E Gschwend; Birgitt Marten-Mittag; Peter Herschbach; Kathleen Herkommer Journal: Fam Cancer Date: 2014-09 Impact factor: 2.375
Authors: Anna Beraldi; Ene Kukk; Alexandra Nest; Gabriele Schubert-Fritschle; Jutta Engel; Pia Heußner; Peter Herschbach Journal: Support Care Cancer Date: 2014-10-17 Impact factor: 3.603
Authors: Florian Pohlig; Ulrich Lenze; Heinrich M L Muhlhofer; Florian W Lenze; Johannes Schauwecker; Carolin Knebel; Tanja Zimmermann; Peter Herschbach Journal: In Vivo Date: 2017 May-Jun Impact factor: 2.155
Authors: K Kirchheiner; A Czajka; E Ponocny-Seliger; E Komarek; G Hohenberg; R Pötter; W Dörr Journal: Strahlenther Onkol Date: 2013-05-25 Impact factor: 3.621
Authors: U Lenze; C Kirchhoff; K Book; F Pohlig; G Gradl; H Rechl; P Herschbach; R von Eisenhart-Rothe Journal: Orthopade Date: 2012-12 Impact factor: 1.087
Authors: Markus W Haun; Halina Sklenarova; Eva C Winkler; Johannes Huber; Michael Thomas; Laura A Siminoff; Michael Woll; Anette Brechtel; Wolfgang Herzog; Mechthild Hartmann Journal: Support Care Cancer Date: 2014-04-11 Impact factor: 3.603